ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 66 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,396,000 | +20.8% | 303,516 | +11.3% | 0.00% | – |
Q3 2016 | $1,156,000 | +84.1% | 272,705 | +4.2% | 0.00% | – |
Q2 2016 | $628,000 | -32.2% | 261,678 | +32.8% | 0.00% | – |
Q1 2016 | $926,000 | +18.9% | 197,074 | -0.5% | 0.00% | – |
Q4 2015 | $779,000 | +10.3% | 198,103 | +8.6% | 0.00% | – |
Q3 2015 | $706,000 | +108.9% | 182,377 | +148.0% | 0.00% | – |
Q2 2015 | $338,000 | +412.1% | 73,531 | +648.1% | 0.00% | – |
Q1 2015 | $66,000 | – | 9,829 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 5,292,156 | $7,144,000 | 0.82% |
Northeast Financial Consultants Inc | 732,265 | $988,000 | 0.30% |
Family Management Corp | 10,424 | $14,000 | 0.01% |
LMR Partners LLP | 81,550 | $110,000 | 0.01% |
ELEMENT CAPITAL MANAGEMENT LLC | 148,528 | $201,000 | 0.01% |
Poehling Capital Management, INC. | 3,302 | $4,000 | 0.00% |
Paloma Partners Management Co | 143,800 | $194,000 | 0.00% |
Founders Capital Management | 3,000 | $4,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 186,254 | $251,000 | 0.00% |
FNY Investment Advisers, LLC | 4,230 | $5,000 | 0.00% |